Genistein suppresses doxorubicin associated genotoxicity in human lymphocytes

Doxorubicin is a well-known DNA intercalating chemotherapy drug that is widely used for treatment of different cancers. Its clinical utility is limited due to the observed genotoxic side effects on healthy cells suggesting that newer combination and genoprotective regimens are urgently needed for th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Beg, Tanveer, Siddique, Yasir H., Ara, Gulshan, Afzal, Mohammad, Azmi, Asfar S.
Formato: Articulo
Lenguaje:Inglés
Publicado: 2011
Materias:
Acceso en línea:http://sedici.unlp.edu.ar/handle/10915/8300
http://www.latamjpharm.org/resumenes/30/7/LAJOP_30_7_1_10.pdf
Aporte de:
id I19-R120-10915-8300
record_format dspace
institution Universidad Nacional de La Plata
institution_str I-19
repository_str R-120
collection SEDICI (UNLP)
language Inglés
topic Farmacia
apoptosis; DNA damage markers; doxorubicin; genistein; genotoxicity; human lymphocyte culture
cáncer
Isoflavonas
Daunorrubicina
Toxicidad
spellingShingle Farmacia
apoptosis; DNA damage markers; doxorubicin; genistein; genotoxicity; human lymphocyte culture
cáncer
Isoflavonas
Daunorrubicina
Toxicidad
Beg, Tanveer
Siddique, Yasir H.
Ara, Gulshan
Afzal, Mohammad
Azmi, Asfar S.
Genistein suppresses doxorubicin associated genotoxicity in human lymphocytes
topic_facet Farmacia
apoptosis; DNA damage markers; doxorubicin; genistein; genotoxicity; human lymphocyte culture
cáncer
Isoflavonas
Daunorrubicina
Toxicidad
description Doxorubicin is a well-known DNA intercalating chemotherapy drug that is widely used for treatment of different cancers. Its clinical utility is limited due to the observed genotoxic side effects on healthy cells suggesting that newer combination and genoprotective regimens are urgently needed for the management of doxorubicin chemotherapy. Some dietary phytochemicals are well known for their protective mechanism of action and genistein from soy is recognized as an anti-oxidant with similar properties. Therefore, the present study investigates the effect of genistein against the genotoxic doses of doxorubicin by assessing chromosomal aberrations, sister chromatid exchanges, cell cycle kinetics, cell viability, apoptosis, and DNA damage markers in cultured human lymphocytes. Our results reveal that genistein treatment significantly suppresses genotoxic damage induced by doxorubicin. It is concluded that genistein has the potential to reduce the genotoxicity induced by anti-cancer drugs, thereby reducing the chances of developing secondary tumors during the therapy.
format Articulo
Articulo
author Beg, Tanveer
Siddique, Yasir H.
Ara, Gulshan
Afzal, Mohammad
Azmi, Asfar S.
author_facet Beg, Tanveer
Siddique, Yasir H.
Ara, Gulshan
Afzal, Mohammad
Azmi, Asfar S.
author_sort Beg, Tanveer
title Genistein suppresses doxorubicin associated genotoxicity in human lymphocytes
title_short Genistein suppresses doxorubicin associated genotoxicity in human lymphocytes
title_full Genistein suppresses doxorubicin associated genotoxicity in human lymphocytes
title_fullStr Genistein suppresses doxorubicin associated genotoxicity in human lymphocytes
title_full_unstemmed Genistein suppresses doxorubicin associated genotoxicity in human lymphocytes
title_sort genistein suppresses doxorubicin associated genotoxicity in human lymphocytes
publishDate 2011
url http://sedici.unlp.edu.ar/handle/10915/8300
http://www.latamjpharm.org/resumenes/30/7/LAJOP_30_7_1_10.pdf
work_keys_str_mv AT begtanveer genisteinsuppressesdoxorubicinassociatedgenotoxicityinhumanlymphocytes
AT siddiqueyasirh genisteinsuppressesdoxorubicinassociatedgenotoxicityinhumanlymphocytes
AT aragulshan genisteinsuppressesdoxorubicinassociatedgenotoxicityinhumanlymphocytes
AT afzalmohammad genisteinsuppressesdoxorubicinassociatedgenotoxicityinhumanlymphocytes
AT azmiasfars genisteinsuppressesdoxorubicinassociatedgenotoxicityinhumanlymphocytes
bdutipo_str Repositorios
_version_ 1764820488158183427